| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/27/2013 | EP2573117A1 Antibodies that bind IL-4 and/or IL-13 and their uses |
| 03/27/2013 | EP2573116A1 Antibodies that bind IL-4 and/or IL-13 and their uses |
| 03/27/2013 | EP2573115A1 Antibodies that bind IL-4 and/or IL-13 and their uses |
| 03/27/2013 | EP2573114A1 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 03/27/2013 | EP2573112A1 Modulation of sirpa - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 03/27/2013 | EP2572729A2 High affinity human antibodies to human nerve growth factor |
| 03/27/2013 | EP2572715A1 Immunostimulatory Combinations |
| 03/27/2013 | EP2572714A1 Immunostimulatory Combinations |
| 03/27/2013 | EP2572203A2 Rapid isolation of monoclonal antibodies from animals |
| 03/27/2013 | EP2572197A1 Method and composition for the diagnosis and monitoring of inflammatory diseases |
| 03/27/2013 | EP2572196A2 Assay for identifying antigens that activate b cell receptors comprising neutralizing antibodies |
| 03/27/2013 | EP2571901A1 Biological materials related to her3 |
| 03/27/2013 | EP2571900A1 Improved anti-serum albumin binding variants |
| 03/27/2013 | EP2571899A1 Novel c3c epitope, antibodies binding thereto, and use thereof |
| 03/27/2013 | EP2571898A2 High-affinity fully functional soluble single-domain human cd4, antibodies, and related fusion proteins |
| 03/27/2013 | EP2571532A2 Il-1 binding proteins |
| 03/27/2013 | CN1961003B Humanized anti-TGF-beta antibodies |
| 03/27/2013 | CN1842541B Compositions and methods for regulating NK cell activity |
| 03/27/2013 | CN1259141B PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays |
| 03/27/2013 | CN103003697A Rapid isolation of monoclonal antibodies from animals |
| 03/27/2013 | CN103003424A Antibody capable of binding to transforming growth factor alpha and having antiproliferative activity on cancer having Ras gene mutation |
| 03/27/2013 | CN103003309A Superior efficacy of CD37 antibodies in CLL blood samples |
| 03/27/2013 | CN103003308A Use of antibodies against ICAM-1 in the treatment of patients with relapsed cancer |
| 03/27/2013 | CN103003307A Monoclonal antibodies against c-Met |
| 03/27/2013 | CN103003306A Antibodies |
| 03/27/2013 | CN103003305A 癌症疫苗 Cancer vaccine |
| 03/27/2013 | CN103003304A Prophylaxis of colorectal and gastrointestinal cancer |
| 03/27/2013 | CN103003303A Improved anti-serum albumin binding variants |
| 03/27/2013 | CN103003302A Humanized and chimeric anti-properdin antibodies |
| 03/27/2013 | CN103003299A Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease |
| 03/27/2013 | CN103002916A Novel anti-cmet antibody |
| 03/27/2013 | CN103002915A Methods and compositions for inhibition of Treg cells |
| 03/27/2013 | CN103002913A Compositions and methods for targeting type I interferon producing cells |
| 03/27/2013 | CN102998461A Quick qualitative detection reagent for wheat globulin in milk and protein drinks and preparation method thereof |
| 03/27/2013 | CN102994482A Endoglucanase separated from erwinia stewartii bacteria |
| 03/27/2013 | CN102994455A Monoclonal antibody and kit for cucumber green mottle mosaic viruses (CGMMVs) |
| 03/27/2013 | CN102994454A Monoclonal antibody hybridoma cell strain of soybean lipoxygenase Lox3 as well as antibody and application of monoclonal antibody |
| 03/27/2013 | CN102994453A Anti-progesterone monoclonal antibody and hybridoma cell generating monoclonal antibody and application thereof |
| 03/27/2013 | CN102993307A Anti-human platelet membrane glycoprotein Ib alpha chimeric antibody |
| 03/27/2013 | CN102993306A High affinity, anti-human IgE antibodies |
| 03/27/2013 | CN102993305A Humanized anti-human epidemic growth factor receptor (EGFR) antibody as well as encoding gene and application thereof |
| 03/27/2013 | CN102993304A Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
| 03/27/2013 | CN102993303A Anti-interferon- alpha antibodies |
| 03/27/2013 | CN102993302A Novel anti-Il 13 antibodies and uses thereof |
| 03/27/2013 | CN102993301A Vibrio cholerae flagellin monoclonal antibody and antigen capture ELISA kit |
| 03/27/2013 | CN102993300A Duck tembusu virus polyclonal antibody and preparation method thereof |
| 03/27/2013 | CN102993299A Food allergens, method of detecting food allergens and method of detecting food allergy-inducing foods |
| 03/27/2013 | CN102993276A Polypeptide derivative with immunocompetence as well as preparation method and application of internal reference antibody of polypeptide derivative with immunocompetence |
| 03/27/2013 | CN102988959A Modulation of NKG2D |
| 03/27/2013 | CN102409028B Enterovirus 71 (EV71) monoclonal antibody and application thereof |
| 03/27/2013 | CN102219856B Vascular Endothelial Growth Factor (VEGF) acceptor 2/CD3 bispecific single-chain antibody |
| 03/27/2013 | CN102190726B Fab segment of human HIV antibody, and coding gene and application thereof |
| 03/27/2013 | CN102099375B Anti-idiotypic monoclonal antibody against envelope protein vp28 of shrimp white spot syndrome virus and the preparation method thereof |
| 03/27/2013 | CN101928347B Anti-carcinoembryonic-antigen (CEA) antibody and application thereof |
| 03/27/2013 | CN101921772B Human antibodies that bind human IL-12 and methods for producing |
| 03/27/2013 | CN101607985B Monoclonal antibody for anti-human CEA, a composition containing same and application thereof |
| 03/27/2013 | CN101528777B Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same |
| 03/27/2013 | CN101448934B Panel cell used for granulocyte antibody detection |
| 03/27/2013 | CN101415438B TOLL like receptor 3 antagonists, methods and uses |
| 03/27/2013 | CN101379085B IL-12/P40 binding proteins |
| 03/27/2013 | CN101294159B Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of hiv infection |
| 03/27/2013 | CN101291954B Modified antigen binding molecules with altered cell signaling activity |
| 03/27/2013 | CN101287765B 基因修饰的抗体组成物 Gene modified antibody composition |
| 03/27/2013 | CN101066997B Human antibodies that bind human IL-12 and methods for producing |
| 03/27/2013 | CN101039700B Vaccine conjugate including a human chorionic gonadotropin beta subunit antigen linked to an anti-mannose receptor (mr) antibody |
| 03/27/2013 | CN101014624B Antigen binding proteins directed against scavenger receptor b1 that inhibit hcv replication |
| 03/26/2013 | US8404826 Mycobacterial antigens expressed under low oxygen tension |
| 03/26/2013 | US8404820 Human monoclonal antibodies against Bacillus anthracis protective antigen |
| 03/26/2013 | US8404819 Crystalline anti-human IL-12 antibodies |
| 03/26/2013 | US8404818 Monoclonal antibodies against orthopoxviruses |
| 03/26/2013 | US8404815 Chimeric, humanized, or human antibody 2A4 |
| 03/26/2013 | US8404813 Engineered anti-IL-23P19 antibodies |
| 03/26/2013 | US8404812 Epitope of CD66C specific to lung adenocarcinoma and antibody recognizing the same |
| 03/26/2013 | US8404811 Humanized anti-EGFL7 antibodies and methods using same |
| 03/26/2013 | US8404807 Mammalian tumor susceptibility genes and their uses |
| 03/26/2013 | US8404459 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof |
| 03/26/2013 | US8404245 Immunization of non-human mammals against Streptococcus equi |
| 03/26/2013 | US8404240 Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment |
| 03/26/2013 | US8404239 Anti-Notch2 NRR antibodies |
| 03/26/2013 | US8404238 huTNFR1 selective antagonists |
| 03/26/2013 | US8404237 Antibodies to the NOTCH1 receptor |
| 03/26/2013 | US8404235 Antagonists of IL-6 to raise albumin and/or lower CRP |
| 03/26/2013 | US8404233 Neutralizing monoclonal antibody against human DLL4 |
| 03/26/2013 | CA2791109A1 Generation of binding molecules |
| 03/26/2013 | CA2790883A1 Antibodies, compositions, and assays for detection of cardiac disease |
| 03/26/2013 | CA2580796C Modified fc molecules having peptides inserted in internal loop regions |
| 03/26/2013 | CA2579141C Hemorrhagic feline calicivirus, calicivirus vaccine and method for preventing calicivirus infection or disease |
| 03/26/2013 | CA2509732C A method for the discrimination and isolation of mammary epithelial stem and colony-forming cells |
| 03/26/2013 | CA2354702C Cancer detection method and reagents |
| 03/26/2013 | CA2312000C Mammalian cytokine-like polypeptide-10 |
| 03/26/2013 | CA2262459C Gene involved in cadasil, method of diagnosis and therapeutic application |
| 03/21/2013 | WO2013040517A2 IMMUNOTHERAPY AND DIAGNOSIS OF MUCORMYCOSIS USING CotH |
| 03/21/2013 | WO2013039969A1 METHODS FOR REDUCING LIPOPROTEIN(a) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9) |
| 03/21/2013 | WO2013039958A1 Antibodies to pcsk9 and uses thereof |
| 03/21/2013 | WO2013039954A1 Anti-gitr antibodies |
| 03/21/2013 | WO2013039889A1 T cell receptors recognizing hla-a1- or hla-cw7-restricted mage |
| 03/21/2013 | WO2013039450A1 Calibration reagent and method |
| 03/21/2013 | WO2013039165A1 Anti-human norovirus gii antibody |
| 03/21/2013 | WO2013038696A1 Molecular marker for early indentification of pleural mesothelioma patients, and expression analysis method for same |
| 03/21/2013 | WO2013038196A1 Method for reversing or inhibiting replicative senescence |